Literature DB >> 21581092

(E)-3-(3-Bromo-phen-yl)-1-(4-methyl-phenyl)prop-2-en-1-one.

Hongqi Li, B K Sarojini, C G D Raj, L N Madhu, H S Yathirajan.   

Abstract

The title compound, C(16)H(13)BrO, was synthesized from the reaction of 3-bromo-benzaldehyde and 4-methyl-acetophenone in the presence of KOH. The mol-ecule adopts an E configuration with respect to the C=C double bond of the propenone unit. The dihedral angle formed by the aromatic rings is 46.91 (14)°. The crystal structure is stabilized by Br⋯Br inter-actions [3.4549 (11) Å].

Entities:  

Year:  2008        PMID: 21581092      PMCID: PMC2959749          DOI: 10.1107/S1600536808034867

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the properties and applications of chalcones, see: Pandey et al. (2005 ▶); Conti (2006 ▶); Lawrence et al. (2001 ▶); Nielsen et al. (2005 ▶); Dominguez et al. (2005 ▶). For related structures, see: Sarojini et al. (2007 ▶) and references cited therein.

Experimental

Crystal data

C16H13BrO M = 301.17 Triclinic, a = 5.8984 (16) Å b = 7.3015 (19) Å c = 15.559 (4) Å α = 83.461 (5)° β = 87.860 (4)° γ = 88.446 (5)° V = 665.1 (3) Å3 Z = 2 Mo Kα radiation μ = 3.08 mm−1 T = 273 (2) K 0.12 × 0.10 × 0.06 mm

Data collection

Bruker SMART CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2004 ▶) T min = 0.709, T max = 0.837 3407 measured reflections 2312 independent reflections 1457 reflections with I > 2σ(I) R int = 0.049

Refinement

R[F 2 > 2σ(F 2)] = 0.058 wR(F 2) = 0.168 S = 1.00 2312 reflections 163 parameters H-atom parameters constrained Δρmax = 0.57 e Å−3 Δρmin = −0.44 e Å−3 Data collection: SMART (Bruker, 2001 ▶); cell refinement: SAINT (Bruker, 2001 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536808034867/rz2257sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536808034867/rz2257Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C16H13BrOZ = 2
Mr = 301.17F(000) = 304
Triclinic, P1Dx = 1.504 Mg m3
Hall symbol: -P 1Melting point = 378–380 K
a = 5.8984 (16) ÅMo Kα radiation, λ = 0.71073 Å
b = 7.3015 (19) ÅCell parameters from 1237 reflections
c = 15.559 (4) Åθ = 2.6–23.7°
α = 83.461 (5)°µ = 3.08 mm1
β = 87.860 (4)°T = 273 K
γ = 88.446 (5)°Block, colourless
V = 665.1 (3) Å30.12 × 0.10 × 0.06 mm
Bruker SMART CCD area-detector diffractometer2312 independent reflections
Radiation source: fine-focus sealed tube1457 reflections with I > 2σ(I)
graphiteRint = 0.049
φ and ω scansθmax = 25.1°, θmin = 2.8°
Absorption correction: multi-scan (SADABS; Sheldrick, 2004)h = −7→6
Tmin = 0.709, Tmax = 0.837k = −8→6
3407 measured reflectionsl = −18→18
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.058Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.168H-atom parameters constrained
S = 1.00w = 1/[σ2(Fo2) + (0.078P)2 + 0.164P] where P = (Fo2 + 2Fc2)/3
2312 reflections(Δ/σ)max < 0.001
163 parametersΔρmax = 0.57 e Å3
0 restraintsΔρmin = −0.44 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.20271 (11)0.91736 (11)0.07283 (4)0.0905 (4)
O1−0.2214 (6)0.7140 (5)0.5453 (2)0.0640 (10)
C10.3158 (8)0.9176 (7)0.1855 (3)0.0522 (13)
C20.1824 (8)0.8504 (7)0.2552 (3)0.0475 (12)
H20.04130.80240.24690.057*
C30.2584 (7)0.8541 (6)0.3379 (3)0.0436 (11)
C40.4711 (8)0.9273 (6)0.3481 (3)0.0474 (12)
H40.52460.93080.40330.057*
C50.6015 (8)0.9939 (7)0.2770 (4)0.0512 (13)
H50.74341.04120.28440.061*
C60.5234 (8)0.9912 (7)0.1949 (4)0.0556 (13)
H60.61001.03850.14660.067*
C70.1059 (7)0.7893 (6)0.4108 (3)0.0458 (12)
H7−0.04290.76730.39780.055*
C80.1579 (8)0.7590 (7)0.4923 (3)0.0519 (13)
H80.30690.77150.50790.062*
C9−0.0197 (8)0.7046 (6)0.5605 (3)0.0476 (12)
C100.0571 (7)0.6411 (6)0.6491 (3)0.0433 (11)
C110.2715 (8)0.5634 (7)0.6637 (4)0.0502 (12)
H110.37180.54910.61720.060*
C120.3359 (8)0.5073 (7)0.7474 (4)0.0518 (13)
H120.47730.45060.75670.062*
C130.1921 (8)0.5347 (7)0.8172 (3)0.0503 (12)
C14−0.0198 (8)0.6113 (7)0.8023 (3)0.0544 (13)
H14−0.11880.62760.84890.065*
C15−0.0881 (8)0.6646 (6)0.7191 (3)0.0468 (12)
H15−0.23220.71640.71010.056*
C160.2693 (12)0.4783 (10)0.9080 (4)0.0823 (19)
H16A0.18750.55020.94740.123*
H16B0.42890.49880.91040.123*
H16C0.24050.34990.92400.123*
U11U22U33U12U13U23
Br10.0839 (5)0.1354 (8)0.0529 (5)−0.0024 (4)−0.0134 (3)−0.0102 (4)
O10.043 (2)0.084 (3)0.064 (2)−0.0043 (17)−0.0094 (17)−0.002 (2)
C10.050 (3)0.063 (3)0.044 (3)0.006 (2)−0.003 (2)−0.005 (2)
C20.038 (2)0.053 (3)0.052 (3)0.001 (2)−0.007 (2)−0.009 (2)
C30.037 (2)0.042 (3)0.052 (3)0.002 (2)0.000 (2)−0.009 (2)
C40.039 (3)0.050 (3)0.055 (3)−0.001 (2)−0.005 (2)−0.015 (2)
C50.039 (3)0.048 (3)0.068 (4)−0.002 (2)−0.004 (3)−0.012 (3)
C60.048 (3)0.060 (3)0.057 (3)0.001 (2)0.007 (2)−0.004 (3)
C70.036 (2)0.045 (3)0.059 (3)−0.002 (2)−0.009 (2)−0.012 (2)
C80.043 (3)0.058 (3)0.056 (3)−0.007 (2)−0.007 (2)−0.010 (3)
C90.042 (3)0.039 (3)0.063 (3)−0.007 (2)0.001 (2)−0.009 (2)
C100.037 (2)0.036 (3)0.057 (3)−0.0047 (19)−0.003 (2)−0.005 (2)
C110.039 (3)0.049 (3)0.062 (3)−0.003 (2)0.011 (2)−0.010 (3)
C120.039 (3)0.046 (3)0.068 (4)0.000 (2)−0.004 (3)0.003 (3)
C130.049 (3)0.047 (3)0.053 (3)−0.007 (2)0.000 (2)−0.001 (2)
C140.047 (3)0.062 (3)0.054 (3)−0.003 (2)0.011 (2)−0.008 (3)
C150.038 (2)0.043 (3)0.058 (3)−0.002 (2)0.005 (2)−0.005 (2)
C160.085 (4)0.091 (5)0.069 (4)0.000 (4)−0.011 (4)0.002 (4)
Br1—C11.899 (5)C8—H80.9300
O1—C91.220 (6)C9—C101.486 (7)
C1—C21.368 (7)C10—C151.383 (7)
C1—C61.370 (7)C10—C111.388 (6)
C2—C31.382 (6)C11—C121.384 (7)
C2—H20.9300C11—H110.9300
C3—C41.398 (6)C12—C131.382 (7)
C3—C71.464 (7)C12—H120.9300
C4—C51.374 (7)C13—C141.373 (7)
C4—H40.9300C13—C161.510 (8)
C5—C61.377 (7)C14—C151.380 (7)
C5—H50.9300C14—H140.9300
C6—H60.9300C15—H150.9300
C7—C81.309 (7)C16—H16A0.9600
C7—H70.9300C16—H16B0.9600
C8—C91.491 (7)C16—H16C0.9600
C2—C1—C6122.1 (5)C10—C9—C8117.6 (4)
C2—C1—Br1118.6 (4)C15—C10—C11119.2 (5)
C6—C1—Br1119.3 (4)C15—C10—C9118.8 (4)
C1—C2—C3119.6 (4)C11—C10—C9122.0 (4)
C1—C2—H2120.2C12—C11—C10119.9 (5)
C3—C2—H2120.2C12—C11—H11120.0
C2—C3—C4118.7 (5)C10—C11—H11120.0
C2—C3—C7117.9 (4)C13—C12—C11120.7 (4)
C4—C3—C7123.3 (4)C13—C12—H12119.7
C5—C4—C3120.4 (5)C11—C12—H12119.7
C5—C4—H4119.8C14—C13—C12119.1 (5)
C3—C4—H4119.8C14—C13—C16121.2 (5)
C4—C5—C6120.4 (4)C12—C13—C16119.7 (5)
C4—C5—H5119.8C13—C14—C15120.9 (5)
C6—C5—H5119.8C13—C14—H14119.6
C1—C6—C5118.7 (5)C15—C14—H14119.6
C1—C6—H6120.6C14—C15—C10120.2 (4)
C5—C6—H6120.6C14—C15—H15119.9
C8—C7—C3126.6 (4)C10—C15—H15119.9
C8—C7—H7116.7C13—C16—H16A109.5
C3—C7—H7116.7C13—C16—H16B109.5
C7—C8—C9120.6 (5)H16A—C16—H16B109.5
C7—C8—H8119.7C13—C16—H16C109.5
C9—C8—H8119.7H16A—C16—H16C109.5
O1—C9—C10120.6 (5)H16B—C16—H16C109.5
O1—C9—C8121.8 (5)
C6—C1—C2—C3−0.7 (7)O1—C9—C10—C15−26.2 (7)
Br1—C1—C2—C3−178.1 (3)C8—C9—C10—C15152.7 (4)
C1—C2—C3—C40.1 (7)O1—C9—C10—C11155.4 (5)
C1—C2—C3—C7177.1 (4)C8—C9—C10—C11−25.7 (6)
C2—C3—C4—C50.0 (7)C15—C10—C11—C121.3 (7)
C7—C3—C4—C5−176.8 (4)C9—C10—C11—C12179.6 (4)
C3—C4—C5—C60.6 (7)C10—C11—C12—C13−2.7 (7)
C2—C1—C6—C51.3 (8)C11—C12—C13—C142.8 (7)
Br1—C1—C6—C5178.7 (4)C11—C12—C13—C16−177.9 (5)
C4—C5—C6—C1−1.3 (7)C12—C13—C14—C15−1.5 (7)
C2—C3—C7—C8170.1 (5)C16—C13—C14—C15179.2 (5)
C4—C3—C7—C8−13.1 (7)C13—C14—C15—C100.1 (7)
C3—C7—C8—C9176.0 (4)C11—C10—C15—C140.0 (7)
C7—C8—C9—O1−11.5 (7)C9—C10—C15—C14−178.4 (4)
C7—C8—C9—C10169.6 (4)
  6 in total

1.  Linked parallel synthesis and MTT bioassay screening of substituted chalcones.

Authors:  N J Lawrence; D Rennison; A T McGown; S Ducki; L A Gul; J A Hadfield; N Khan
Journal:  J Comb Chem       Date:  2001 Sep-Oct

2.  Synthesis and antimalarial activity of sulfonamide chalcone derivatives.

Authors:  José N Domínguez; Caritza León; Juan Rodrigues; Neira Gamboa de Domínguez; Jiri Gut; Philip J Rosenthal
Journal:  Farmaco       Date:  2005-04

3.  Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.

Authors:  Simon F Nielsen; Mogens Larsen; Thomas Boesen; Kristian Schønning; Hasse Kromann
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

Review 4.  Cyclopentenone: a special moiety for anticancer drug design.

Authors:  Matteo Conti
Journal:  Anticancer Drugs       Date:  2006-10       Impact factor: 2.248

5.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

6.  Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents.

Authors:  Susmita Pandey; S N Suryawanshi; Suman Gupta; V M L Srivastava
Journal:  Eur J Med Chem       Date:  2005-08       Impact factor: 6.514

  6 in total
  1 in total

1.  (E)-3-(4-Bromo-phen-yl)-1-(3,4-dichloro-phen-yl)prop-2-en-1-one.

Authors:  Rajni Kant; B Narayana; K Veena; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.